Literature DB >> 7718490

A transgenic mouse model for lung adenocarcinoma.

A Sandmöller1, R Halter, G Suske, D Paul, M Beato.   

Abstract

Lung cancer is a leading cause of tumor-related deaths in humans but its origin and development are poorly understood. To study the biology of these tumors, appropriate animal and cell culture models will be of eminent importance. Uteroglobin is a marker protein for the nonciliated epithelial Clara cells lining the respiratory and terminal bronchioli of the lung. We have used the promoter and 5'-flanking sequences of the rabbit uteroglobin gene to target expression of the SV40 T antigen to the lung of transgenic mice. All transgenic founders as well as the descendants from an established line, UT7.1, developed multifocal bronchioloalveolar adenocarcinomas originating from Clara cells. At least three different stages in tumor development with progressive loss of the differentiated phenotype can be distinguished by immunohistochemical data and in situ hybridization. Only in the initial stage did bronchiolar cells express both uteroglobin and SV40 T antigen, whereas at later stages, only SV40 T antigen was detected, and the most advanced tumors were negative for both proteins. Starting from the lungs of UT7.1 mice, a bronchiolar cell line was established that maintains the features of differentiated Clara cells. This system provides a useful model for further studying the development and progression of lung adenocarcinomas in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718490

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  2 in total

1.  Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells.

Authors:  A Geick; P Redecker; A Ehrhardt; R Klocke; D Paul; R Halter
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

2.  Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.

Authors:  Z Zhang; G C Kundu; D Panda; A K Mandal; G Mantile-Selvaggi; A Peri; C J Yuan; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.